Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Improving the management of chronic inflammatory demyelinating polyradiculoneuropathy.
Alteration of the cytokine signature by various TLR ligands in different T cell populations in MOG37-50 and MOG35-55-induced EAE in C57BL/6 mice.
[Improving the sexual quality of life of people with multiple sclerosis].
Programmed cell death and natural killer cells in multiple sclerosis: new potential therapeutic targets?
A pilot study of changes in functional brain activity during a working memory task after mSMT treatment: The MEMREHAB trial.
Neuromyelitis optica and pregnancy.
Matrix metalloproteinases in the brain and blood-brain barrier: versatile breakers and makers.
Reproducibility measurement of glutathione, GABA, and glutamate: Towards in vivo neurochemical profiling of multiple sclerosis with MR spectroscopy at 7T.
[Multiple sclerosis vaccine: possibilities of the use of dendritic cells immunomodulatory potential].
IDO-orchestrated crosstalk between pDCs and Tregs inhibits autoimmunity.
[Anesthesia and Multiple Sclerosis: What needs to be considered?].
Delayed iron deposit and atrophy of the putamen in a case with osmotic demyelination syndrome.
Recent trends in the transdermal delivery of therapeutic agents used for the management of neurodegenerative diseases.
Enantioselective total synthesis of the highly selective sphingosine-1-receptor VPC01091 by the Heck desymmetrization of a non-activated cyclopentene-fused spiro-pyrrolidinone.
Multiple sclerosis is accompanied by lack of KIR2DS1 gene: A meta-analysis.
Cholesterol Biosynthesis Supports Myelin Gene Expression and Axon Ensheathment through Modulation of P13K/Akt/mTor Signaling.
Extensive and severe CNS demyelination associated with golimumab therapy.
IFN-β Facilitates Neuroantigen-Dependent Induction of CD25+ FOXP3+ Regulatory T Cells That Suppress Experimental Autoimmune Encephalomyelitis.
Stress Urinary Incontinence in Women With Multiple Sclerosis.
25-hydroxycholesterol contributes to cerebral inflammation of X-linked adrenoleukodystrophy through activation of the NLRP3 inflammasome.
Toll-Like Receptor 2 Mediates In Vivo Pro- and Anti-inflammatory Effects of Mycobacterium Tuberculosis and Modulates Autoimmune Encephalomyelitis.
Examining the Relationship Between Family Caregivers' Emotional States and Ability to Empathize with Patients with Multiple Sclerosis: A Pilot Study.
High Intensity Aerobic and Resistance Exercise Can Improve Glucose Tolerance in Persons With Multiple Sclerosis: A Randomized Controlled Trial.
Dysautonomic polyneuropathy as a variant of chronic inflammatory "demyelinating" polyneuropathy?
Gut microbiome analysis in neuromyelitis optica reveals over-abundance of Clostridium perfringens.
Pages
« first
‹ previous
…
841
842
843
844
845
846
847
848
849
…
next ›
last »